In particular, mice bearing melanoma, mesothelioma, or pancreatic cancer experienced a better treatment outcome when a high percentage of CD26+ donor T cells infiltrated the tumor, suggesting that a CD26 played a crucial role in tumor immunity, which could entail several mechanisms [30]. This evidence concerns the gene DPP4 and mesothelioma.